IQV vs NTRA
IQVIA and Natera, Inc., both Healthcare
Natera, Inc. is the larger company at $33B against $28B. Over the past year NTRA returned +140% against +47% for IQV. Ryufin's sector-relative Smart Score puts NTRA ahead, 10/10 against 9/10.
| Figure | IQV | NTRA |
|---|---|---|
| Last close | $262 | $339 |
| Market cap | $28B | $33B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 32.5 | n/a |
| 1-year return | +47% | +140% |
| 5-year return | +5.6% | +201% |
| Ryufin Smart Scoresector-relative, 1–10 | 9/10 | 10/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
IQVIA
Revenue of $4.2B in Q1 2026, net income $274M. Its largest reported line is Research And Development Solutions, 56% of the disclosed total.
Natera, Inc.
Revenue of $753M in Q2 2026, net income null. Its largest reported line is US, 98% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.